ProShare Advisors’s Fate Therapeutics FATE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$29.8K Sell
26,640
-171
-0.6% -$192 ﹤0.01% 2041
2025
Q1
$21.2K Sell
26,811
-6,834
-20% -$5.4K ﹤0.01% 2032
2024
Q4
$55.5K Buy
33,645
+14,728
+78% +$24.3K ﹤0.01% 2166
2024
Q3
$66.2K Buy
18,917
+7,566
+67% +$26.5K ﹤0.01% 1943
2024
Q2
$37.2K Sell
11,351
-3,876
-25% -$12.7K ﹤0.01% 1773
2024
Q1
$112K Buy
15,227
+1,199
+9% +$8.8K ﹤0.01% 1804
2023
Q4
$52.5K Sell
14,028
-3,424
-20% -$12.8K ﹤0.01% 1855
2023
Q3
$37K Buy
17,452
+63
+0.4% +$134 ﹤0.01% 1743
2023
Q2
$82.8K Buy
17,389
+800
+5% +$3.81K ﹤0.01% 1725
2023
Q1
$94.6K Sell
16,589
-3,394
-17% -$19.3K ﹤0.01% 1601
2022
Q4
$202K Buy
19,983
+1,347
+7% +$13.6K ﹤0.01% 1496
2022
Q3
$418K Buy
18,636
+427
+2% +$9.58K ﹤0.01% 977
2022
Q2
$450K Sell
18,209
-8,844
-33% -$219K ﹤0.01% 982
2022
Q1
$1.05M Sell
27,053
-6,155
-19% -$239K ﹤0.01% 902
2021
Q4
$1.94M Buy
33,208
+562
+2% +$32.9K ﹤0.01% 767
2021
Q3
$1.94M Sell
32,646
-5,016
-13% -$297K 0.01% 725
2021
Q2
$3.27M Buy
37,662
+4,360
+13% +$378K 0.01% 599
2021
Q1
$2.75M Buy
33,302
+3,969
+14% +$327K 0.01% 603
2020
Q4
$2.67M Buy
29,333
+6,559
+29% +$596K 0.01% 570
2020
Q3
$910K Buy
22,774
+1,846
+9% +$73.8K ﹤0.01% 749
2020
Q2
$718K Buy
20,928
+6,974
+50% +$239K ﹤0.01% 800
2020
Q1
$310K Sell
13,954
-10,615
-43% -$236K ﹤0.01% 863
2019
Q4
$481K Buy
24,569
+942
+4% +$18.4K ﹤0.01% 1072
2019
Q3
$367K Sell
23,627
-1,822
-7% -$28.3K ﹤0.01% 1119
2019
Q2
$517K Sell
25,449
-3,064
-11% -$62.2K ﹤0.01% 1001
2019
Q1
$501K Buy
28,513
+243
+0.9% +$4.27K ﹤0.01% 1020
2018
Q4
$363K Buy
+28,270
New +$363K ﹤0.01% 1056